Quick Facts
- Type Essential mineral
- RDA (adult men) 400–420 mg/day
- RDA (adult women) 310–320 mg/day
- UL (supplemental only) 350 mg/day
- Deficiency prevalence ~48% of US adults below EAR
- Best-absorbed forms Glycinate, citrate, taurate
- Strongest evidence for Blood pressure, diabetes, migraine
What Is Magnesium
Magnesium is the fourth most abundant mineral in the human body and a cofactor in more than 300 enzymatic reactions. It plays critical roles in energy production, protein synthesis, muscle and nerve function, blood sugar regulation, and blood pressure control. It is also essential for bone formation, DNA synthesis, and the active transport of calcium and potassium across cell membranes.
Despite its importance, magnesium deficiency is described as "a widespread and underrecognized global public health concern."[1] NHANES data estimates that approximately 48% of the US population consumes less than the Estimated Average Requirement from food alone. Subclinical deficiency is far more common than overt hypomagnesemia and is difficult to detect — serum magnesium represents only ~1% of total body stores, making standard blood tests an unreliable marker.[2]
What the Evidence Shows
Magnesium has been studied across a wide range of health conditions. The table below summarizes the evidence strength for each, based on the quantity and quality of randomized controlled trials and meta-analyses available.
| Condition | Evidence | Key Finding |
|---|---|---|
| Blood pressure | Strong | Reduces SBP by ~2 mmHg and DBP by ~1.78 mmHg (34 RCTs, 2,028 participants)[3] |
| Type 2 diabetes | Strong | ~500 mg/day reduces HbA1c by -0.73% and fasting glucose by -7 to -16 mg/dL[4] |
| Migraine prevention | Strong | Oral Mg reduces migraine frequency (OR 0.20) and intensity (OR 0.27) across 10 RCTs[5] |
| Depression | Moderate | Significant reduction in depression scores (SMD -0.92) across 7 RCTs[6] |
| Sleep / insomnia | Moderate | May reduce sleep onset latency by ~17 min in older adults; 5 of 8 studies positive[7] |
| Bone health | Moderate | Higher intake associated with higher hip BMD in adults 60+[8] |
| Constipation | Moderate | Mg oxide/hydroxide are established osmotic laxatives (pharmacological, not nutritional effect) |
| Anxiety | Limited | Some small RCTs suggest benefit; no robust magnesium-specific meta-analysis exists |
| Muscle cramps | Insufficient | Cochrane review (11 RCTs, 735 participants): "unlikely to provide clinically meaningful cramp prophylaxis"[9] |
Deep Dives by Condition
Forms Compared
Not all magnesium supplements are equal. A 2021 systematic review of 14 studies confirmed that organic forms (chelated with amino acids or organic acids) are more bioavailable than inorganic forms, and absorption is dose-dependent — splitting doses improves total absorption.[10]
| Form | Bioavailability | Notes |
|---|---|---|
| Glycinate (bisglycinate) | High | Well-tolerated, minimal GI effects. Glycine itself may have calming properties. Preferred for deficiency correction. |
| Citrate | High | Well-absorbed. Mild laxative effect at higher doses. Good general-purpose form. |
| Taurate | High | Chelated with taurine. Often marketed for cardiovascular support. |
| Malate | High | Chelated with malic acid. Sometimes marketed for energy and muscle pain. |
| L-Threonate | Moderate–High | Studied for brain penetration. Heavily marketed for cognition but has zero meta-analyses on PubMed as of 2026. Evidence is primarily from animal studies. |
| Chloride | Moderate | Better absorbed than oxide. Available orally and topically. |
| Oxide | Low (~4%) | Highest elemental Mg per dose but poorly absorbed. Primarily useful as a laxative. |
Recommended Dietary Allowances
| Age Group | Male | Female | Pregnant |
|---|---|---|---|
| 1–3 years | 80 mg | 80 mg | — |
| 4–8 years | 130 mg | 130 mg | — |
| 9–13 years | 240 mg | 240 mg | — |
| 14–18 years | 410 mg | 360 mg | 400 mg |
| 19–30 years | 400 mg | 310 mg | 350 mg |
| 31–50 years | 420 mg | 320 mg | 360 mg |
| 51+ years | 420 mg | 320 mg | — |
The Tolerable Upper Intake Level (UL) for supplemental magnesium is 350 mg/day for adults. This limit applies only to magnesium from supplements and medications — magnesium from food and water does not count toward this limit and does not pose a toxicity risk.[11]
Safety & Drug Interactions
Common Side Effects
Diarrhea, nausea, and abdominal cramping are the most frequent side effects, especially with poorly absorbed forms (oxide, carbonate, chloride, gluconate). The Cochrane review on muscle cramps reported GI side effects in 11–37% of magnesium groups vs 10–14% of placebo groups.[9]
Populations Who Should Be Cautious
- Impaired kidney function: The kidneys are responsible for magnesium excretion. Toxicity risk increases significantly in people with kidney disease.
- People on diuretics or PPIs: Loop diuretics, thiazide diuretics, and long-term proton pump inhibitor use can deplete magnesium — but supplementation should be guided by a healthcare provider.
- High-dose zinc users: Zinc intake above 142 mg/day can interfere with magnesium absorption.
Drug Interactions
| Drug Class | Interaction | Management |
|---|---|---|
| Bisphosphonates (alendronate) | Mg decreases absorption | Take bisphosphonate 2+ hrs before Mg |
| Tetracycline antibiotics | Mg chelates and reduces absorption | Separate by 2–3 hours |
| Quinolone antibiotics (cipro) | Mg chelates and reduces absorption | Take 2 hrs before or 4–6 hrs after |
| Loop/thiazide diuretics | Increase urinary Mg loss | Monitor magnesium status |
| Proton pump inhibitors | Long-term use causes hypomagnesemia | Measure levels periodically (FDA warning) |
Severe Toxicity
Extremely rare with oral supplements at standard doses. Serum concentrations above 1.74–2.61 mmol/L can cause hypotension, facial flushing, difficulty breathing, irregular heartbeat, and cardiac arrest. This risk is primarily associated with IV magnesium or oral overdose in individuals with severely impaired kidney function.[11]
References
- "Dietary magnesium deficiency: a widespread and underrecognized global public health concern." 2025. PMID: 41504160. PubMed
- "Magnesium health effects and deficiency burden." 2025. PMID: 41305676. PubMed
- Zhang X, et al. "Effects of Magnesium Supplementation on Blood Pressure." Hypertension. 2016;68(2):324-333. 34 RCTs, 2,028 participants. PubMed
- Asbaghi O, et al. "Magnesium supplementation and glycemic control in type 2 diabetes: dose-response meta-analysis." 2022. 18 RCTs. PMID: 35045911. PubMed
- Chiu HY, et al. "Effects of Intravenous and Oral Magnesium on Reducing Migraine: A Meta-analysis of Randomized Controlled Trials." 2016. 21 RCTs. PMID: 26752497. PubMed
- Moabedi M, et al. "Magnesium supplementation and depression: a systematic review and meta-analysis." Front Psychiatry. 2023. 7 RCTs, 325 participants. PubMed
- Mah J, Pitre T. "Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis." BMC Complement Med Ther. 2021;21(1):125. PubMed
- Groenendijk I, et al. "Magnesium and bone health in older adults." 2022. 12 observational studies. PMID: 34666201. PubMed
- Garrison SR, et al. "Magnesium for skeletal muscle cramps." Cochrane Database Syst Rev. 2020. 11 RCTs, 735 participants. PubMed
- Pardo MR, et al. "Bioavailability of magnesium food supplements: A systematic review." Nutrition. 2021. 14 studies. PMID: 34111673. PubMed
- National Institutes of Health, Office of Dietary Supplements. "Magnesium — Health Professional Fact Sheet." Updated 2024. NIH ODS